Patents by Inventor Christopher Matthew Liu

Christopher Matthew Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE
    Publication number: 20230277573
    Abstract: Aspects of the disclosure relate to oligosaccharide compositions and methods of making the same. Also provided are methods of using oligosaccharide compositions as microbiome metabolic therapies for reducing levels and/or concentration of glucose and/or lipids, e.g., cholesterol, low-density lipoprotein cholesterol, non-esterified free fatty acids and triglycerides, and for the treatment of related diseases.
    Type: Application
    Filed: July 16, 2021
    Publication date: September 7, 2023
    Inventors: Yves MILLET, Jeffrey MEISNER, Christopher Matthew LIU, Lingyao LI
  • Methods of producing glycan polymers
    Patent number: 11697692
    Abstract: Preparations of glycan polymers and variations thereof, pharmaceutical compositions, medical foods, supplements, foods, food ingredients, feed ingredients, and feed additives thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same.
    Type: Grant
    Filed: November 3, 2018
    Date of Patent: July 11, 2023
    Assignee: DSM Nutritional Products, LLC
    Inventors: John M. Geremia, Christopher Matthew Liu, Anastasia V. Lioubomirov
  • OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING VIRAL INFECTIONS
    Publication number: 20230165881
    Abstract: Aspects of the disclosure relate to oligosaccharide compositions and methods of making the same. Also provided are methods of using oligosaccharide compositions as microbiome metabolic therapies for treating respiratory viral illnesses, such as COVID-19.
    Type: Application
    Filed: April 29, 2021
    Publication date: June 1, 2023
    Inventors: Jonathan Lawrence, Jeffrey Meisner, Christopher Matthew Liu, Madeline Rosini, Max Hecht, Mark Wingertzahn, Geoffrey A. von Maltzahn
  • OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE
    Publication number: 20220233560
    Abstract: Aspects of the disclosure relate to oligosaccharide compositions and methods of making the same. Also provided are methods of using oligosaccharide compositions as microbiome metabolic therapies for reducing pathogen levels and/or abundance and for the treatment of related diseases.
    Type: Application
    Filed: May 8, 2020
    Publication date: July 28, 2022
    Applicant: Kaleido Biosciences, Inc.
    Inventors: Tatyana Yatsunenko, Jonathan Lawrence, Madeline Rosini, Max Hecht, Christopher Matthew Liu
  • Oligosaccharide compositions and methods of use thereof
    Patent number: 11169101
    Abstract: Aspects of the disclosure relate to oligosaccharide compositions and methods of making the same. Also provided are methods of using oligosaccharide compositions as microbiome metabolic therapies for reducing ammonia levels and for the treatment of related diseases.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: November 9, 2021
    Assignee: Kaleido Biosciences, Inc.
    Inventors: Christopher Matthew Liu, Anastasia Lioubomirov, John M. Geremia, Mitchell Antalek, Jonathan Lawrence, Tatyana Yatsunenko, Brian Meehan
  • OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE THEREOF FOR REDUCING AMMONIA LEVELS
    Publication number: 20210198302
    Abstract: Aspects of the disclosure relate to oligosaccharide compositions and methods of making the same. Also provided are methods of using oligosaccharide compositions as microbiome metabolic therapies for reducing ammonia levels and for the treatment of hyperammonemia-related diseases (e.g., urea cycle disorders and hepatic encephalopathy).
    Type: Application
    Filed: August 21, 2019
    Publication date: July 1, 2021
    Applicant: Kaleido Biosciences, Inc.
    Inventors: Christopher Matthew Liu, John M. Geremia, Anastasia Lioubomirov, Max Hecht
  • OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20210164926
    Abstract: Aspects of the disclosure relate to oligosaccharide compositions and methods of making the same. Also provided are methods of using oligosaccharide compositions as microbiome metabolic therapies for reducing ammonia levels and for the treatment of related diseases.
    Type: Application
    Filed: January 25, 2021
    Publication date: June 3, 2021
    Applicant: Kaleido Biosciences, Inc.
    Inventors: Christopher Matthew Liu, Anastasia Lioubomirov, John M. Geremia, Mitchell Antalek, Jonathan Lawrence, Tatyana Yatsunenko, Brian Meehan
  • GLYCAN POLYMERS AND RELATED METHODS THEREOF
    Publication number: 20200390798
    Abstract: Compositions of glycan polymers and methods of making and manufacturing the same are described herein. Also provided are methods of treating a disease or disorder with a glycan polymer preparation.
    Type: Application
    Filed: January 21, 2020
    Publication date: December 17, 2020
    Inventors: Molly Krisann Gibson, Christopher Matthew Liu, Geoffrey A. von Maltzahn, Han Yuan
  • METHODS OF PRODUCING GLYCAN POLYMERS
    Publication number: 20200354481
    Abstract: Preparations of glycan polymers and variations thereof, pharmaceutical compositions, medical foods, supplements, foods, food ingredients, feed ingredients, and feed additives thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same.
    Type: Application
    Filed: November 3, 2018
    Publication date: November 12, 2020
    Inventors: John M. Geremia, Christopher Matthew Liu, Anastasia V. Murphy
  • GLYCAN POLYMERS AND RELATED METHODS THEREOF
    Publication number: 20190290675
    Abstract: Compositions of glycan polymers and methods of making and manufacturing the same are described herein. Also provided are methods of treating a disease or disorder with a glycan polymer preparation.
    Type: Application
    Filed: December 6, 2017
    Publication date: September 26, 2019
    Inventors: Molly Krisann Gibson, Christopher Matthew Liu, Geoffrey A. von Maltzahn, Han Yuan
  • INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL
    Publication number: 20170050966
    Abstract: The present invention relates to compounds of the Formula (I), or a pharmaceutically acceptable salt, pharmaceutical preparation, or pharmaceutical composition thereof, and their use for the treatment of pain, inflammatory disease, neuropathy, dermatological disorders, pulmonary conditions, and cough, as well as inhibiting the Transient Receptor Potential A1 ion channel (TRPA1).
    Type: Application
    Filed: April 23, 2015
    Publication date: February 23, 2017
    Inventors: Blaise S. Lippa, Xinyuan Wu, Qingyi Li, Iwona Wrona, Andrew J. Jackson, Bertrand L. Chenard, Christopher Matthew Liu, Guohua Liang, Matthew F. Baevsky, Richard Alan Earl, Lisa Mcqueen, Jared Smit, Brett A. Cowans